Neutropenia during tocilizumab treatment is not associated with infection risk in systemic or polyarticular-course juvenile idiopathic arthritis

M. Pardeo, J. Wang, N. Ruperto, E. Alexeeva, V. Chasnyk, R. Schneider, G. Horneff, H.-I. Huppertz, K. Minden, K. Onel, L. Zemel, A. Martin, I. Koné-Paut, A. Siamopoulou-Mavridou, C.A. Silva, B. Porter-Brown, K.N. Bharucha, H.I. Brunner, F. De Benedetti, for the Paediatric Rheumatology International Trials Organisation (PRINTO) and the Pediatric Rheumatology Collaborative Study Group (PRCSG)

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)1117-1126
Number of pages10
JournalJournal of Rheumatology
Volume46
Issue number9
DOIs
Publication statusPublished - 2019

Cite this

Pardeo, M., Wang, J., Ruperto, N., Alexeeva, E., Chasnyk, V., Schneider, R., ... (PRCSG), F. T. P. R. I. T. O. PRINTO. A. T. P. R. C. S. G. (2019). Neutropenia during tocilizumab treatment is not associated with infection risk in systemic or polyarticular-course juvenile idiopathic arthritis. Journal of Rheumatology, 46(9), 1117-1126. https://doi.org/10.3899/jrheum.180795